-
As the global population ages, there is a concurrent persistence of high-risk behaviors among individuals aged 50 and older, leading to an escalating incidence of human immunodeficiency virus (HIV) infections within this demographic (1). Data from China indicates a consistent rise in the proportion of people aged 50 and above living with HIV/acquired immune deficiency syndrome (AIDS) (PLWHA) (2). Research suggests that the reported infection rates for HIV/AIDS vary with age, with a notably higher incidence recorded among the elderly, defined as persons aged 50 years and older (3). Extensive literature indicates that HIV transmission has extended beyond high-risk populations to infect the general population, particularly the elderly. Yet, the majority of prior studies have primarily concentrated on high-risk behaviors in the 15–49 age cohort, with little comparative analysis on the epidemiological characteristics of HIV/AIDS cases among individuals aged 15–49 years and those aged 50 and above. This study seeks to address this gap by investigating the epidemiological trends and demographic attributes of HIV/AIDS cases in China, stratified by age groups over and under 50 years, reported between 2010 and 2022. The objective is to elucidate the current epidemiological landscape of HIV among these populations and to propose age-specific interventions tailored to each group.
-
In China, the number of newly reported HIV/AIDS cases in the 15–49 age group increased from 51,436 in 2010 to 55,397 in 2022, while it increased from 11,751 in 2010 to 51,856 in 2022 in the group aged ≥50 years. In the male group, the percentage of individuals aged 50 and older with HIV/AIDS saw a significant increase from 19.57% in 2010 to 44.39% in 2022 (χ2=30,268.80, P<0.01). Similarly, among females, the percentage of HIV/AIDS in those aged 50 and above rose markedly from 16.26% in 2010 to 62.78% in 2022 (χ2=12,529.83, P<0.01). Among new diagnoses in China, males aged between 15 and 49 accounted for 79.24% of cases, resulting in a gender ratio of 3.82∶1. Among the demographic aged 50 and older, 73.34% of cases were male, with a reduced gender ratio of 2.75∶1 (Figure 1).
Figure 1.Frequency of HIV/AIDS cases in individuals aged 15–49 and ≥50 years, and proportion of HIV/AIDS cases in individuals aged ≥50 years between male and female in China, 2010–2022.
Abbreviation: HIV=human immunodeficiency virus; AIDS=acquired immunodeficiency syndrome.The trend in detection rates of HIV/AIDS case from 2010 to 2022 was rising, with a little decline after 2019. For males, the detection rate of HIV/AIDS cases in the ≥50 age group exceeded that of the 15–49 age group around 2017. Conversely, in females, the detection rates remained relatively stable across both age groups, although the detection rate for those aged 50 and over was greater than that for the 15–49 cohort beginning around 2014 (Figure 2). A comparative analysis of the annual new detection rates for HIV/AIDS cases across different gender and age groups revealed an upward trend for males aged 50 and above, with rates climbing from 0.5 per 10,000 in 2010 to 2.2 per 10,000 in 2019, before the trend reversed and fell to 1.5 per 10,000 by 2022. Joinpoint regression analysis indicated an APC of 18.3% [95% confidence interval (CI): 16.1%, 20.6%] from 2010 to 2018 and an APC of −8.0% (95% CI: −11.2%, −4.6%) from 2018 to 2022. In females aged 50 and over, detection rates rose from 0.2 per 10,000 in 2010 to 0.8 per 10,000 in 2019, then similarly reversed, decreasing to 0.6 per 10,000 in 2022. Joinpoint regression analysis for this group showed an APC of 19.2% (95% CI: 17.2%, 21.4%) from 2010 to 2018 and an APC of −6.7% (95% CI: −9.6%, −3.7%) from 2018 to 2022 (Table 1).
Figure 2.The trending change in the detection rate of HIV/AIDS cases in individuals aged 15–49 and ≥50 years old in China, 2010–2022.
Abbreviation: HIV=human immunodeficiency virus; AIDS=acquired immunodeficiency syndrome.Age, years AAPC, % (95% CI) t P Year APC, % (95% CI) t P Male 15–49 3.8 (0.8, 6.8) 2.5 0.013 2010–2015 12.8 (8.1, 17.6) 7.3 0.001 2015–2019 3.2 (−4.4, 11.4) 1.0 0.343 2019–2022 −8.9 (−16.6, −0.5) −2.7 0.041 ≥50 8.8 (7.2, 10.4) 11.2 <0.001 2010–2018 18.3 (16.1, 20.6) 20.5 < 0.001 2018–2022 −8.0 (−11.2, −4.6) −5.4 0.001 Female 15–49 −3.5 (−5.3, −1.7) −3.7 <0.001 2010–2019 1 (−0.1, 2.2) 2.0 0.079 2019–2022 −15.8 (−22.3, −8.7) −4.9 0.001 ≥50 9.9 (8.4, 11.4) 13.8 <0.001 2010–2018 19.2 (17.2, 21.4) 23.1 < 0.001 2018–2022 −6.7 (−9.6, −3.7) −5.1 0.001 Abbreviation: HIV=human immunodeficiency virus; AIDS=acquired immunodeficiency syndrome; AAPC=average annual percent change; APC=annual percent change; CI=confidence interval. Table 1. Annual percent change in detection rate of HIV/AIDS in individuals aged 15–49 and ≥50 years old in China, 2010–2022.
In 2022, significant disparities were observed among different age cohorts, distinguished by gender. Our analysis revealed that men and women across these groups presented statistically significant dissimilarities in terms of educational background, marital status, occupation, transmission route, site of diagnosis, and region (P<0.01). Furthermore, when comparing age groups, distinct patterns in transmission routes emerged (χ2=72,936.81, P<0.01).
In the 15–49 age category, heterosexual transmission was predominant, accounting for 55.62% (30,813/55,397) of cases. This trend was even more pronounced in those aged 50 and above, with heterosexual transmission representing 90.16% (46,754/51,856) of instances. Notably, among men aged 15–49, homosexual transmission constituted a significant proportion at 50.13% (23,463/46,802). In contrast, the rate for homosexual transmission was markedly lower in men aged 50 and above, at 11.04% (4,125/37,358).
In terms of female cases, however, non-mainstream non-commercial heterosexual contact (NMNCHC) (12,595/22,448, 56.11%) was identified as the primary transmission route for both age brackets, at 70.65% and 64.33%, respectively, as detailed in Table 2.
Characteristics Male Female 15–49 years
(n=46,802)≥50 years
(n=37,358)χ2 15–49 years
(n=8,595)≥50 years
(n=14,498)χ2 Ethnicity Han 39,965 (85.39) 33,655 (90.09) 422.2* 5,553 (64.61) 12,133 (83.69) 1,102.1* Others 6,837 (14.61) 3,703 (9.91) 3,042 (35.39) 2,365 (16.31) Marital status Single 12,484 (26.67) 21,476 (57.49) 23,465.9* 4,876 (56.73) 8,887 (61.30) 2,178.1* Married or living with partner 27,959 (59.74) 3,208 (8.59) 1,384 (16.10) 109 (0.75) Divorced or widowed 6,141 (13.12) 12,522 (33.52) 2,296 (26.71) 5,452 (37.61) Unknown 218 (0.47) 152 (0.42) 39 (0.45) 50 (0.34) Occupation Farming 12,856 (27.47) 24,475 (65.51) 12,284.7* 4,273 (49.71) 9,720 (67.04) 749.1* Housekeeping service or
unemployment11,666 (24.93) 5,142 (13.76) 2,322 (27.02) 2,969 (20.48) Others 22,280 (47.60) 7,741 (20.72) 2,000 (23.27) 1,809 (12.48) Education Primary school or illiterate 6,988 (14.93) 21,734 (58.18) 23,289.4* 3,687 (42.90) 10,407 (71.78) 2,259.1* Junior high school 13,625 (29.11) 11,111 (29.74) 3,164 (36.81) 3,275 (22.59) High school 9,619 (20.55) 3,199 (8.56) 1,069 (12.44) 654 (4.51) College and above 16,570 (35.40) 1,314 (3.52) 675 (7.85) 162 (1.12) Transmission route Heterosexual 22,448 (47.96) 32,516 (87.04) 14,632.7* 8,365 (97.32) 1,4238 (98.21) 36.86* Homosexual 23,463 (50.13) 4,125 (11.04) - - Injecting drugs 287 (0.61) 86 (0.23) 47 (0.55) 21 (0.14) Others 604 (1.29) 631 (1.69) 183 (2.13) 239 (1.65) Site of diagnosis Hospital 26,048 (55.66) 26,997 (72.27) 3,143.3* 5,279 (61.42) 9,484 (65.42) 42.8* High-risk population screening 15,999 (34.18) 6,447 (17.26) 2,341 (27.24) 3,656 (25.22) Others 4,755 (10.16) 3,914 (10.48) 975 (11.35) 1,358 (9.36) Regions North China 4,275 (9.13) 1,322 (3.54) 4,245.1* 220 (2.56) 268 (1.85) 476.4* Northeast 2,727 (5.83) 818 (2.19) 154 (1.79) 213 (1.47) East China 10,424 (22.27) 5,813 (15.56) 1,048 (12.19) 1,799 (12.41) South Central 13,793 (29.47) 11,676 (31.25) 2,132 (24.81) 4,527 (31.22) Southwest 12,424 (26.55) 16,304 (43.64) 4,188 (48.73) 7,187 (49.57) Northwest 3,159 (6.75) 1,425 (3.81) 853 (9.92) 504 (3.48) CD4+T cells (cells/μL) 0–199 11,890 (25.40) 13,171 (35.26) 2,295.7* 2,041 (23.75) 4,351 (30.01) 215.4* 200–349 12,510 (26.73) 10,029 (26.85) 2,388 (27.78) 4,376 (30.18) 350–500 8,965 (19.16) 4,832 (12.93) 1,642 (19.10) 2,302 (15.88) 501– 7,142 (15.26) 2,942 (7.88) 1,375 (16.00) 1,631 (11.25) Undetected 6,295 (13.45) 6,384 (17.09) 1,149 (13.37) 1,838 (12.68) Abbreviation: HIV=human immunodeficiency virus; AIDS=acquired immunodeficiency syndrome.
* P<0.01.Table 2. Characteristics of newly reported HIV/AIDS cases aged 15–49 and ≥50 years in China, 2022 (n, %).
HTML
Citation: |